Intelligent OMICS Ltd (Intellomx) is a UK-based AI company that discovers new drugs. We use proprietary technology to identify the biological targets that research has missed and we then progress drug development from idea to IND. We collaborate with others via fee-for-service projects but we also practice what we preach, applying our own technology in-house. We currently seek partners for our lung cancer/KRAS drugs, identified using our own technology. Contact us if we can help you discover drugs for your pipeline too. Technology: Our systems approach is called "Intuitive Informed Intelligence". Our technology approach is based on high speed creation of Artificial Neural Networks (ANNs) which can evaluate tens of millions of data in short period of time, to identity key drivers for systems biology. And to connect these drives to therapeutic modalities including new drugs, repurposed drugs and biomarker panels for disease. Intellomx uses novel proprietary Artificial Intelligence approaches applied to translational biology to discover new drugs for old diseases identify existing drugs for new targets create new diagnostics to stratify patient populations We transform biological data into clinical benefit! Come join the AI-driven drug discovery revolution.